Recombinant human granulocyte/macrophage colony-stimulating factor (Guangzhou Baiyunshan Baidi Biotechnology)

重组人粒细胞/巨噬细胞集落刺激因子（白云山拜迪）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human granulocyte/macrophage colony-stimulating factor (Guangzhou Baiyunshan Baidi Biotechnology)
Drug Alias NamerhGM-CSF (Guangzhou Baiyunshan Baidi Biotechnology)Molgramostim biosimilar (Guangzhou Baiyunshan Baidi Biotechnology)Molgramostim follow-on biologic (Guangzhou Baiyunshan Baidi Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsLeukopeniaMyelodysplastic Syndromes
Global Approved IndicationsLeukopeniaMyelodysplastic Syndromes
Approved Indications in ChinaLeukopeniaMyelodysplastic Syndromes
Original Approved Country/TerritoryMainland China
Original Approved Date2005/10/10
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangzhou Baiyunshan Pharmaceutical Holdings Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Baiyunshan Baidi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukopeniaMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A